Orchestra BioMed Holdings (OBIO) Other Non-Current Assets (2020 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Other Non-Current Assets came in at $1.3 million in Q1 2026, down 1.56% year-on-year from $1.3 million in Q1 2025, and up 1.94% on a QoQ basis from $1.2 million in Q4 2025.
Orchestra BioMed Holdings (OBIO) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 6 years of Other Non-Current Assets data on file, last reported at $1.3 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 1.56% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 1.56% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, up 21.57% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.3 million, up from $1.2 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for OBIO reached as high as $4.7 million in Q4 2022 and fell as low as $421000.0 in Q1 2023.
- Historically, Other Non-Current Assets has averaged $1.2 million across 5 years, with a median of $1.1 million in 2024.
- Across the five-year window, Other Non-Current Assets slumped 83.68% in 2023 and soared 115.73% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $4.7 million in 2022, then slumped by 83.68% to $769000.0 in 2023, then soared by 32.64% to $1.0 million in 2024, then climbed by 21.57% to $1.2 million in 2025, then climbed by 1.94% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | 1.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.26 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 841,000.00 |
| Mar 31, 2024 | 894,000.00 |
| Dec 31, 2023 | 769,000.00 |
| Sep 30, 2023 | 604,000.00 |
| Jun 30, 2023 | 517,000.00 |
| Mar 31, 2023 | 421,000.00 |
| Dec 31, 2022 | 4.71 Mn |
| Dec 31, 2020 | 162.16 Mn |